Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 4 studies | 32% ± 16% | |
hepatocyte | 4 studies | 63% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 20196.19 | 226 / 226 | 86% | 163.94 | 350 / 406 |
kidney | 97% | 1456.01 | 86 / 89 | 4% | 0.67 | 39 / 901 |
pancreas | 88% | 20.30 | 288 / 328 | 1% | 0.08 | 2 / 178 |
stomach | 75% | 31.72 | 268 / 359 | 0% | 0 | 0 / 286 |
skin | 24% | 2.35 | 436 / 1809 | 0% | 0.01 | 1 / 472 |
peripheral blood | 22% | 8.94 | 200 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 17% | 1.29 | 43 / 258 | 1% | 0.11 | 2 / 230 |
uterus | 17% | 1.99 | 29 / 170 | 0% | 0 | 0 / 459 |
spleen | 15% | 19.18 | 37 / 241 | 0% | 0 | 0 / 0 |
prostate | 15% | 0.95 | 36 / 245 | 0% | 0 | 0 / 502 |
intestine | 11% | 0.93 | 108 / 966 | 0% | 0.35 | 1 / 527 |
ovary | 11% | 1.42 | 20 / 180 | 0% | 0 | 0 / 430 |
lung | 11% | 0.99 | 63 / 578 | 0% | 0.18 | 2 / 1155 |
adipose | 10% | 3.62 | 125 / 1204 | 0% | 0 | 0 / 0 |
thymus | 9% | 0.93 | 62 / 653 | 0% | 0 | 0 / 605 |
esophagus | 9% | 0.86 | 125 / 1445 | 1% | 0.05 | 1 / 183 |
breast | 9% | 2.70 | 41 / 459 | 0% | 0 | 0 / 1118 |
blood vessel | 7% | 0.79 | 94 / 1335 | 0% | 0 | 0 / 0 |
heart | 6% | 0.78 | 54 / 861 | 0% | 0 | 0 / 0 |
muscle | 5% | 0.32 | 37 / 803 | 0% | 0 | 0 / 0 |
brain | 4% | 0.32 | 112 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051180 | Biological process | vitamin transport |
GO_0071693 | Biological process | protein transport within extracellular region |
GO_0050821 | Biological process | protein stabilization |
GO_0005615 | Cellular component | extracellular space |
GO_0072562 | Cellular component | blood microparticle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0008431 | Molecular function | vitamin E binding |
Gene name | AFM |
Protein name | Afamin (Alpha-albumin) (Alpha-Alb) |
Synonyms | ALB2 ALBA |
Description | FUNCTION: Functions as a carrier for hydrophobic molecules in body fluids (Probable). Essential for the solubility and activity of lipidated Wnt family members, including WNT1, WNT2B, WNT3, WNT3A, WNT5A, WNT7A, WNT7B, WNT8, WNT9A, WNT9B, WNT10A and WNT10B . Binds vitamin E . May transport vitamin E in body fluids under conditions where the lipoprotein system is not sufficient . May be involved in the transport of vitamin E across the blood-brain barrier . . |
Accessions | ENST00000226355.5 P43652 |